Literature DB >> 19159937

[Drug therapy during pregnancy and breast feeding. Updated summary].

K Krüger1, E Gromnica-Ihle.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19159937     DOI: 10.1007/s00393-008-0423-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  48 in total

1.  Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al.

Authors:  Rolando Cimaz; Antonio Brucato; Elisa Meregalli; Marina Muscará; Paola Sergi
Journal:  Arthritis Rheum       Date:  2004-09

Review 2.  Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature.

Authors:  Nathalie Costedoat-Chalumeau; Zahir Amoura; Du Le Thi Huong; Philippe Lechat; Jean-Charles Piette
Journal:  Autoimmun Rev       Date:  2004-12-14       Impact factor: 9.754

3.  Cyclophosphamide in human milk.

Authors:  P H Wiernik; J H Duncan
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

4.  Intrauterine contraceptive device failures in renal transplant patients.

Authors:  J Zerner; K L Doil; J Drewry; D A Leeber
Journal:  J Reprod Med       Date:  1981-02       Impact factor: 0.142

5.  Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.

Authors:  B Bar Oz; R Hackman; T Einarson; G Koren
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

Review 6.  Low dose weekly methotrexate in early pregnancy. A case series and review of the literature.

Authors:  M Ostensen; H Hartmann; K Salvesen
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

7.  Disease specific problems related to drug therapy in pregnancy.

Authors:  M Ostensen
Journal:  Lupus       Date:  2004       Impact factor: 2.911

8.  The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients.

Authors:  David Norman Moskovitz; Carol Bodian; Mark L Chapman; James F Marion; Peter H Rubin; Ellen Scherl; Daniel H Present
Journal:  Am J Gastroenterol       Date:  2004-04       Impact factor: 10.864

9.  Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.

Authors:  D T Boumpas; H A Austin; E M Vaughan; C H Yarboro; J H Klippel; J E Balow
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

10.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Shannon M Bates; Ian A Greer; Ingrid Pabinger; Shoshanna Sofaer; Jack Hirsh
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

View more
  2 in total

1.  [Pregnancy and inflammatory rheumatic diseases].

Authors:  R Fischer-Betz; E Gromnica-Ihle
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

2.  [Safety of immunosuppressants].

Authors:  O Psenak; A Studnicka-Benke; R Greil
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.